Literature DB >> 17493625

Family history of diabetes and risk of atherosclerotic cardiovascular disease in Korean men and women.

Ji Wan Park1, Ji Eun Yun, Taesung Park, Eorin Cho, Sun Ha Jee, Yangsu Jang, Terri H Beaty, Jonathan M Samet.   

Abstract

The importance of family history of type 2 diabetes (FHD) as a risk factor for atherosclerotic cardiovascular disease (ASCVD) remains controversial. A report of diabetes in parents and siblings was used to establish FHD in a cohort of 1,005,230 Koreans aged 30-95 years insured by the National Health Insurance Corporation who had a biennial medical evaluation during 1992-1995. ASCVD morbidity and mortality from 1993 to 2005 were examined in relation to FHD and other ASCVD risk factors. The risk of ischemic heart disease (IHD) increased significantly (19%) in men with FHD but not in women. A strong interaction was observed between FHD and personal history of diabetes for the occurrence of ASCVD; men with both diabetes and FHD were at significantly increased risk of developing IHD, cerebrovascular disease and ASCVD with hazard ratios (HR) of 2.28, 2.07, and 2.12, respectively, compared to those who had neither FHD nor type 2 diabetes. Corresponding risks were 2.64, 2.03, and 2.10 in women, respectively. This study demonstrates that risk of ASCVD is increased among those with diabetes and a family history of diabetes; suggesting that genetic factors associated with occurrence of familial diabetes may increase risk of ASCVD beyond the risk among people without FHD.

Entities:  

Mesh:

Year:  2007        PMID: 17493625     DOI: 10.1016/j.atherosclerosis.2007.03.037

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention.

Authors:  Janice S Dorman; Rodolfo Valdez; Tiebin Liu; Catharine Wang; Wendy S Rubinstein; Suzanne M O'Neill; Louise S Acheson; Mack T Ruffin; Muin J Khoury
Journal:  Diabetes Res Clin Pract       Date:  2012-01-17       Impact factor: 5.602

2.  Risk factors for coronary heart disease in patients below 45 years of age.

Authors:  Mansoor Nadeem; Syed Shahzad Ahmed; Sarah Mansoor; Sidra Farooq
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

3.  Increased risk of metabolic disorders in healthy young adults with family history of diabetes: from the Korea National Health and Nutrition Survey.

Authors:  Joon Ho Moon; Eun Roh; Tae Jung Oh; Kyoung Min Kim; Jae Hoon Moon; Soo Lim; Hak Chul Jang; Sung Hee Choi
Journal:  Diabetol Metab Syndr       Date:  2017-03-01       Impact factor: 3.320

4.  Association of Percentage Body Fat and Metabolic Health in Offspring of Patients with Cardiovascular Diseases.

Authors:  Yuan-Yuei Chen; Wen-Hui Fang; Chung-Ching Wang; Tung-Wei Kao; Yaw-Wen Chang; Hui-Fang Yang; Chen-Jung Wu; Yu-Shan Sun; Wei-Liang Chen
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

5.  Relation of familial patterns of coronary heart disease, stroke, and diabetes to subclinical atherosclerosis: the multi-ethnic study of atherosclerosis.

Authors:  Maren T Scheuner; Claude Messan Setodji; James S Pankow; Roger S Blumenthal; Emmett Keeler
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

6.  Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes.

Authors:  Xiang Hu; Xiaojing Ma; Yuqi Luo; Yiting Xu; Qin Xiong; Xiaoping Pan; Yuqian Bao; Weiping Jia
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

7.  Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohorts.

Authors:  Kristin Mühlenbruch; Juliane Menzel; Marcus Dörr; Till Ittermann; Christa Meisinger; Annette Peters; Alexander Kluttig; Daniel Medenwald; Manuela Bergmann; Heiner Boeing; Matthias B Schulze; Cornelia Weikert
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.